Serum Institute is optimistic that its pneumococcal vaccine will be available in India by June 2020. The vaccine is yet to be approved by the DCGI. But phase-3 trial data from Gambia has already been submitted to DCGI and the agency has looked into the data. The Indian phase-3 trial data has now been submitted. … Continue reading ‘Serum’s pneumococcal vaccine will be available by June 2020’
Pneumococcal vaccine
WHO prequalifies Serum’s low-cost pneumococcal vaccine
WHO has prequalified Pune-based Serum Institute’s pneumococcal conjugate vaccine made of 10 serotypes that are widely prevalent and cause pneumonia in Latin America, Africa and Asia. The vaccine will cost only $2 per dose, which is 30% cheaper than the Gavi price. The phase-3 trial data has been submitted to DCGI for licensing. Pneumococcal vaccine … Continue reading WHO prequalifies Serum’s low-cost pneumococcal vaccine
Science Chronicle 